C79.11
Secondary malignant neoplasm of bladder
Clinical Classification Guidelines
Excludes Type 2
- lymph node metastases (C77.0)
Medical Intelligence & Overview
Secondary malignant neoplasm of the bladder, coded as C79.11 in ICD-10, refers to cancer that has spread to the bladder from a primary site elsewhere in the body. This condition indicates metastasis, meaning the cancer cells have traveled through the bloodstream or lymphatic system to reach the bladder. While the bladder itself may not have originally developed cancer, the presence of secondary tumors can significantly impact health and treatment options. Recognizing the characteristics and implications of secondary bladder cancer is essential for understanding the disease's complexity and management.
Causes & Symptoms
Clinical Causes: Primary cancers from other parts of the body such as the colon, breasts, or lungs that metastasize to the bladder Spread of melanoma or renal cell carcinoma to the bladder Advancement of known cancers with secondary involvement of the bladder tissue In some cases, extensive systemic disease indicating widespread metastatic activity
Key Symptoms: Hematuria (blood in the urine) Persistent urinary tract infections or inflammation Pain or discomfort in the lower abdomen or pelvis Frequent or urgent urination Urinary retention or difficulty urinating Unexplained weight loss or fatigue in advanced cases
Diagnostic & Treatment
Diagnosis Path: Medical history review focusing on known primary cancers Urinalysis to detect blood or abnormal cells Imaging studies such as CT scans, MRI, or PET scans to visualize tumors and check for other metastatic sites Cystoscopy — a procedure where a thin tube with a camera is inserted into the bladder to examine its interior Biopsy of bladder tissue to confirm cancer and identify the primary source if unknown Laboratory tests to evaluate overall health and organ function
Treatment Protocols: Systemic therapies such as chemotherapy, targeted therapy, or immunotherapy aimed at controlling cancer spread Localized treatments like radiation therapy to alleviate symptoms or reduce tumor size in the bladder Surgical interventions, which may include removal of bladder tumors or, in some cases, cystectomy (bladder removal), depending on the disease stage Supportive care to manage symptoms, improve quality of life, and address complications Multidisciplinary approach involving oncologists, urologists, and palliative care teams
Clinical Advice & FAQs
Billing Guidance
Is C79.11 a billable ICD-10 code?
Yes, C79.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C79.11?
Clinical documentation must specify the nature of Secondary malignant neoplasm of bladder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference